Dimethylformamide → 1,3-Bis(3-methoxypropyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
반응식
[CH:1]([C:3]1[C:4](=[O:10])[NH:5][C:6](=[O:9])[NH:7][CH:8]=1)=[O:2].Br[CH2:12][CH2:13][CH2:14][O:15][CH3:16].[CH2:17]1[CH2:27]CN2C(=NCCC2)C[CH2:18]1.CN([CH:31]=[O:32])C>>[CH3:16][O:15][CH2:14][CH2:13][CH2:12][N:7]1[CH:8]=[C:3]([CH:1]=[O:2])[C:4](=[O:10])[N:5]([CH2:18][CH2:17][CH2:27][O:32][CH3:31])[C:6]1=[O:9]참가 물질
5
실험 절차
To a DMF (0.35 M) solution of 5-formyluracil (1 eq.) was added sequentially at 0° C. 1-bromo-3-methoxypropane (2.2 eq.) and DBU (2.2 eq.). The resulting solution was stirred at RT for 72 h. The volatiles were then removed in vacuo. The crude product mixture thus obtained was directly subjected to purification by way of column chromatography (SiO2, EtOAc) to afford the title compound as a yellow oil.
후처리
- customThe volatiles were then removed in vacuo
- customThe crude product mixture thus obtained
- customwas directly subjected to purification by way of column chromatography (SiO2, EtOAc)
출처 및 근거
- ORD 기록
- ord-cde0f4ebe46b4a7b8cbb8028d434ae96
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08889714B2
반응 노트
불러오는 중…